Literature DB >> 22576633

Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010.

Jackie Soo1, Mayris P Webber2, Charles B Hall3, Hillel W Cohen3, Theresa M Schwartz1, Kerry J Kelly4, David J Prezant1.   

Abstract

BACKGROUND: We examined the relationship between pulmonary function (FEV 1 ) and confirmed recovery from three lower-respiratory symptoms (LRSs) (cough, dyspnea, and wheeze) up to 9 years after symptom onset.
METHODS: The study included white and black male World Trade Center (WTC)-exposed firefighters who reported at least one LRS on a medical monitoring examination during the fi rst year after September 11, 2001. Confirmed recovery was defined as reporting no LRSs on two consecutive and all subsequent examinations. FEV 1 was assessed at the fi rst post-September 11, 2001, examination and at each examination where symptom information was ascertained. We used stratified Cox regression models to analyze FEV 1 , WTC exposure, and other variables in relation to confirmed symptom recovery.
RESULTS: A total of 4,368 fi refighters met inclusion criteria and were symptomatic at year 1, of whom1,592 (36.4%) experienced confirmed recovery. In univariable models, fi rst post-September 11,2001, concurrent, and difference between fi rst post-September 11, 2001, and concurrent FEV 1 values were all significantly associated with confirmed recovery. In adjusted analyses, both fi rst post-September 11, 2001, FEV 1 (hazard ratio [HR], 1.07 per 355-mL difference; 95% CI, 1.04-1.10) and FEV 1 % predicted (HR, 1.08 per 10% predicted difference; 95% CI, 1.04-1.12) predicted confirmed recovery. WTC exposure had an inverse association with confirmed recovery in the model with FEV 1 , with the earliest arrival group less likely to recover than the latest arrival group (HR, 0.73;95% CI, 0.58-0.92).
CONCLUSIONS: Higher FEV 1 and improvement in FEV 1 after September 11, 2001, predicted confirmed LRS recovery, supporting a physiologic basis for recovery and highlighting consideration of spirometry as part of any postexposure respiratory health assessment.

Entities:  

Mesh:

Year:  2012        PMID: 22576633      PMCID: PMC3494475          DOI: 10.1378/chest.11-2210

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

1.  Rapid declines in FEV1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States.

Authors:  L A Beeckman; M L Wang; E L Petsonk; G R Wagner
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center.

Authors:  Gisela I Banauch; Dawn Alleyne; Raoul Sanchez; Kattia Olender; Hillel W Cohen; Michael Weiden; Kerry J Kelly; David J Prezant
Journal:  Am J Respir Crit Care Med       Date:  2003-02-25       Impact factor: 21.405

3.  Cough and bronchial responsiveness in firefighters at the World Trade Center site.

Authors:  David J Prezant; Michael Weiden; Gisela I Banauch; Georgeann McGuinness; William N Rom; Thomas K Aldrich; Kerry J Kelly
Journal:  N Engl J Med       Date:  2002-09-09       Impact factor: 91.245

4.  Respiratory symptoms were associated with lower spirometry results during the first examination of WTC responders.

Authors:  Iris Udasin; Clyde Schechter; Laura Crowley; Anays Sotolongo; Michael Gochfeld; Benjamin Luft; Jacqueline Moline; Denise Harrison; Paul Enright
Journal:  J Occup Environ Med       Date:  2011-01       Impact factor: 2.162

5.  Case-control study of lung function in World Trade Center Health Registry area residents and workers.

Authors:  Stephen M Friedman; Carey B Maslow; Joan Reibman; Parul S Pillai; Roberta M Goldring; Mark R Farfel; Steven D Stellman; Kenneth I Berger
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

6.  Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study.

Authors:  H J Schünemann; J Dorn; B J Grant; W Winkelstein; M Trevisan
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

7.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Authors:  R E Kanner; N R Anthonisen; J E Connett
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

8.  Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  T M Davis; M Knuiman; P Kendall; H Vu; W A Davis
Journal:  Diabetes Res Clin Pract       Date:  2000-10       Impact factor: 5.602

9.  Geographical information system and environmental epidemiology: a cross-sectional spatial analysis of the effects of traffic-related air pollution on population respiratory health.

Authors:  Daniela Nuvolone; Roberto Della Maggiore; Sara Maio; Roberto Fresco; Sandra Baldacci; Laura Carrozzi; Francesco Pistelli; Giovanni Viegi
Journal:  Environ Health       Date:  2011-03-01       Impact factor: 5.984

10.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

View more
  8 in total

Review 1.  Airway Disease in Rescue/Recovery Workers: Recent Findings from the World Trade Center Collapse.

Authors:  Krystal L Cleven; Mayris P Webber; Rachel Zeig-Owens; Kerry M Hena; David J Prezant
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

Review 2.  Destruction of the World Trade Center Towers. Lessons Learned from an Environmental Health Disaster.

Authors:  Joan Reibman; Nomi Levy-Carrick; Terry Miles; Kimberly Flynn; Catherine Hughes; Michael Crane; Roberto G Lucchini
Journal:  Ann Am Thorac Soc       Date:  2016-05

Review 3.  Biomarkers of World Trade Center Particulate Matter Exposure: Physiology of Distal Airway and Blood Biomarkers that Predict FEV₁ Decline.

Authors:  Michael D Weiden; Sophia Kwon; Erin Caraher; Kenneth I Berger; Joan Reibman; William N Rom; David J Prezant; Anna Nolan
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

Review 4.  Implications of the World Trade Center Health Program (WTCHP) for the public health response to the Great East Japan Earthquake.

Authors:  Michael A Crane; Hyunje G Cho; Phillip J Landrigan
Journal:  Ind Health       Date:  2013-12-09       Impact factor: 2.179

5.  Estimating the time interval between exposure to the World Trade Center disaster and incident diagnoses of obstructive airway disease.

Authors:  Michelle S Glaser; Mayris P Webber; Rachel Zeig-Owens; Jessica Weakley; Xiaoxue Liu; Fen Ye; Hillel W Cohen; Thomas K Aldrich; Kerry J Kelly; Anna Nolan; Michael D Weiden; David J Prezant; Charles B Hall
Journal:  Am J Epidemiol       Date:  2014-06-30       Impact factor: 4.897

6.  Incomplete lung recovery following sub-acute inhalation of combustion-derived ultrafine particles in mice.

Authors:  A Noël; R Xiao; Z Perveen; H M Zaman; R L Rouse; D B Paulsen; A L Penn
Journal:  Part Fibre Toxicol       Date:  2016-02-24       Impact factor: 9.400

7.  Respiratory symptoms and lung function 8-10 months after community exposure to chlorine gas: a public health intervention and cross-sectional analysis.

Authors:  Kathleen A Clark; Debjani Chanda; Pallavi Balte; Wilfried J Karmaus; Bo Cai; John Vena; Andrew B Lawson; Lawrence C Mohr; James J Gibson; Erik R Svendsen
Journal:  BMC Public Health       Date:  2013-10-09       Impact factor: 3.295

8.  Lung function decline before and after treatment of World Trade Center associated obstructive airways disease with inhaled corticosteroids and long-acting beta agonists.

Authors:  David G Goldfarb; Barbara Putman; Lies Lahousse; Rachel Zeig-Owens; Brandon M Vaeth; Theresa Schwartz; Charles B Hall; David J Prezant; Michael D Weiden
Journal:  Am J Ind Med       Date:  2021-07-13       Impact factor: 3.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.